KYTX logo

Kyverna Therapeutics (KYTX) Operating Profit

Annual Operating Profit

-$62.41 M
-$33.02 M-112.38%

December 31, 2023


Summary


Performance

KYTX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXprofitabilitymetrics:

Quarterly Operating Profit

-$38.77 M
-$5.33 M-15.96%

September 30, 2024


Summary


Performance

KYTX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXprofitabilitymetrics:

TTM Operating Profit

-$122.94 M
-$22.49 M-22.39%

September 30, 2024


Summary


Performance

KYTX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

KYTX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-112.4%-81.4%-97.0%
3 y3 years-136.9%-81.4%-97.0%
5 y5 years-136.9%-81.4%-97.0%

KYTX Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-136.9%at low-341.8%at low-1301.0%at low
5 y5-year-136.9%at low-341.8%at low-1301.0%at low
alltimeall time-136.9%at low-341.8%at low-1301.0%at low

Kyverna Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$38.77 M(+16.0%)
-$122.94 M(+22.4%)
Jun 2024
-
-$33.44 M(+13.9%)
-$100.45 M(+25.1%)
Mar 2024
-
-$29.36 M(+37.3%)
-$80.32 M(+28.7%)
Dec 2023
-$62.41 M
-$21.38 M(+31.3%)
-$62.41 M(+25.3%)
Sep 2023
-
-$16.28 M(+22.4%)
-$49.80 M(+48.6%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$13.30 M(+16.2%)
-$33.52 M(+65.8%)
Mar 2023
-
-$11.45 M(+30.4%)
-$20.22 M(+130.4%)
Dec 2022
-$29.38 M(+11.5%)
-
-
Dec 2022
-
-$8.78 M
-$8.78 M
Dec 2021
-$26.35 M
-
-

FAQ

  • What is Kyverna Therapeutics annual operating income?
  • What is the all time high annual operating profit for Kyverna Therapeutics?
  • What is Kyverna Therapeutics annual operating profit year-on-year change?
  • What is Kyverna Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Kyverna Therapeutics?
  • What is Kyverna Therapeutics quarterly operating profit year-on-year change?
  • What is Kyverna Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Kyverna Therapeutics?
  • What is Kyverna Therapeutics TTM operating profit year-on-year change?

What is Kyverna Therapeutics annual operating income?

The current annual operating profit of KYTX is -$62.41 M

What is the all time high annual operating profit for Kyverna Therapeutics?

Kyverna Therapeutics all-time high annual operating income is -$26.35 M

What is Kyverna Therapeutics annual operating profit year-on-year change?

Over the past year, KYTX annual operating income has changed by -$33.02 M (-112.38%)

What is Kyverna Therapeutics quarterly operating income?

The current quarterly operating profit of KYTX is -$38.77 M

What is the all time high quarterly operating profit for Kyverna Therapeutics?

Kyverna Therapeutics all-time high quarterly operating income is -$8.78 M

What is Kyverna Therapeutics quarterly operating profit year-on-year change?

Over the past year, KYTX quarterly operating income has changed by -$17.39 M (-81.36%)

What is Kyverna Therapeutics TTM operating income?

The current TTM operating profit of KYTX is -$122.94 M

What is the all time high TTM operating profit for Kyverna Therapeutics?

Kyverna Therapeutics all-time high TTM operating income is -$8.78 M

What is Kyverna Therapeutics TTM operating profit year-on-year change?

Over the past year, KYTX TTM operating income has changed by -$60.53 M (-97.00%)